AlphaMaven AlphaMaven

Coinbase Just Got Slammed: Barclays Slashes Price Target to $107 After Q1 Crypto Trading Miss - 24/7 Wall St.

Reported by 247wallst
May 8, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Barclays downgraded Coinbase (COIN) from Neutral to Underweight with a $140 price target, representing a 23% downside from the stock's trading level near $181 and well below the stock's year-to-date decline of 20% from $226.14.
  • • Q1 2026 earnings miss driven by sharp declines in trading volumes and consumer transaction revenue drop exceeding 45%, reflecting weak crypto market conditions and structural headwinds to the exchange's business model.
  • • Fee compression intensifying as institutional capital migrates directly to asset-specific ETFs (including Morgan Stanley's Bitcoin Trust at 0.14% annual fee) and away from traditional exchange-based trading, squeezing Coinbase's revenue margins.
  • • Stablecoin ecosystem disruption: transaction volumes reached $33 trillion in 2025, exceeding Visa and Mastercard combined, with B2B payments increasingly settling on direct rails rather than through Coinbase's platform.
  • • Broader analyst consensus remains mixed: 52% of 27 analysts covering COIN rate it Strong Buy, but Barclays' Underweight call reflects concerns about structural competitiveness and macro crypto cyclicality headwinds.
Summary
Barclays initiated coverage of Coinbase Global with an Underweight rating and a $140 price target on Wednesday, marking a significant bearish pivot ahead of the company's Q1 2026 earnings announcement. The downgrade came after Barclays cut its prior neutral stance and reduced its price target from $148, signaling deepening concerns about the cryptocurrency exchange's competitive positioning and near-term earnings trajectory. Coinbase shares fell more than 5% in extended trading following the Q1 earnings release, which revealed a surprise loss and revenue miss as crypto trading volumes contracted sharply.

The core of Barclays' thesis centers on multiple structural headwinds eroding Coinbase's traditionally high-margin trading business. Fee compression represents an acute threat: institutional asset managers are increasingly bypassing traditional crypto exchanges entirely, instead routing capital into dedicated cryptocurrency ETFs and trusts. Morgan Stanley's newly launched Bitcoin Trust, operating at a 0.14% annual fee, exemplifies this trend and undercuts the revenue model on which Coinbase has historically relied. Institutional investors' preference for direct asset ownership through regulated vehicles rather than exchange-based intermediation reflects a maturation of the institutional crypto market that disadvantages Coinbase's platform economics.

The stablecoin landscape presents an additional structural challenge. Transaction volumes on stablecoin networks reached $33 trillion during 2025, surpassing combined Visa and Mastercard volumes, yet this activity increasingly bypasses Coinbase as B2B payments migrate to direct settlement rails. This shift reduces the transaction volume dependency that has historically driven significant portions of Coinbase's revenue. Q1 results underscored these pressures, with consumer transaction revenue declining more than 45% as crypto market activity weakened and user engagement contracted.

Despite Barclays' bearish call, broader analyst sentiment remains split. Of 27 analysts covering Coinbase, 52% maintain Strong Buy ratings and 22% recommend Buy, though 19% suggest holding and 8% advise selling or strong selling. The stock has declined 20% year-to-date, mirroring Bitcoin's performance and underscoring the tight correlation between Coinbase's equity and broader cryptocurrency market sentiment. For institutional investors, the Barclays downgrade reflects a growing view that structural competitive dynamics—rather than near-term crypto cycle recovery alone—represent a material headwind to Coinbase's long-term earnings power and valuation sustainability.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial